Cloud-clone
SKU:RPA794Ra01
Recombinant Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)
Recombinant Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)
Couldn't load pickup availability
Prokaryotic expression
Product No.
RPA794Ra01
Organism Species
Rattus norvegicus (Rat).
Source
Prokaryotic expression
Host
E.coli
Endotoxin Level
<1.0EU per 1µg (determined by the LAL method)
Subcellular Location
Nucleus, Cytoplasm
Predicted Molecular Mass
20.3kDa
Accurate Molecular Mass
21kDa(Analysis of differences refer to the manual)
Residues & Tags
Ser3~Pro155 with N-terminal His Tag
Buffer Formulation
20mM Tris, 150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300.
Traits
Freeze-dried powder
Purity
> 97%
Isoelectric Point
9.1
Applications
Positive Control; Immunogen; SDS-PAGE; WB.
If bio-activity of the protein is needed, please check active protein.
UOM
10µg 50µg 200µg 1mg 5mg
SEQUENCE
USAGE
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
STORAGE
Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
| Magazine | Citations |
| Biochemical genetics | Comparison of Selected Protein Levels in Tumour and Surgical Margin in a Group of Patients with Oral Cavity Cancer pubmed:28421310 |
| European Journal of Pharmaceutical Sciences | Development of core-shell nanocarrier system for augmenting piperine cytotoxic activity against human brain cancer cell line Pubmed:29597041 |
| Clinical and Experimental Medicine | Senescence-associated miR-34a and miR-126 in middle-aged Indians with type 2 diabetes Pubmed: 31732824 |
| MOLECULAR AND CELLULAR BIOCHEMISTRY | Tumor suppressor genes are differentially regulated with dietary folate modulations in a rat model of hepatocellular carcinoma Pubmed: 32974833 |
| Catalog No. | Related products for research use of Rattus norvegicus (Rat) Organism species | Applications (RESEARCH USE ONLY!) |
| RPA794Ra01 | Recombinant Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA794Ra01 | Polyclonal Antibody to Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) | WB; IHC; ICC; IP. |
